Report cover image

Japan Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Indu

Publisher Allied Market Research
Published Jun 02, 2023
Length 86 Pages
SKU # ALMR18790539

Description

Japan Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032


Point-of-care glucose testing involves measurement of blood glucose levels of the patient at the point of care or bedside. It does not include sending blood samples for analysis to the laboratory. It is commonly used in the management of diabetes. Products used for point-of-care glucose testing include strips, lancets and lancing devices, and meters.

The Japan point-of-care glucose testing market is expected to witness substantial growth in the coming years owing to the surge in awareness of diabetes among consumers, government-led initiatives, and enterprises committing to enhancing healthcare across the country.

Further, stringent regulatory requirements for approval of glucose meters and other point-of-care glucose testing devices restrains the growth of the market in Japan.

Technological advancements such as wireless connectivity for glucose testing which helped monitor and maintain a record of the glucose levels without human involvement, attract the customers who are aware of the importance of maintaining a record of the glucose levels, and prefer to do so from the comfort of their home. This increases the demand for such devices, in turn, fostering the growth of the Japan point-of-care glucose testing market.

The Japan point-of-care glucose testing market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan one touch ultra & Lifescan one touch verio; Accuchek Aviva Plus & Accuchek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.

Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S and OLYMPUS CORPORATION are some of the major players in the Japan point-of-care glucose testing market. Further, five emerging companies in the market include Bionovate, ARKRAY USA Inc., Diatrics, Ciphergen Biosystems, and LifeScan. Companies in Japan are focusing on partnerships and collaborations to sustain the intense competition in the market.

New product developments, are thus, observed and expected in the Japan point-of-care glucose monitoring market, as the country adopts advanced technologies to manage healthcare facilities. The future of the Japan point-of-care glucose monitoring market is thus marked by integration of technology, stringent regulations, and patient-centric design, which play a pivotal role in shaping its growth in the coming years.

The Japan point-of-care glucose testing market is anticipated to witness growth during the forecast period owing to technological advancements and adoption of IoT or wireless technologies. A lot of people prefer home care settings to monitor their health. To cater the same, a lot of companies are coming up with wireless monitoring devices which enable the patient to monitor the health from home and similarly feed and maintain the data remotely in the laboratory. This also prevents the patients from visiting the laboratory. These is an increase in demand for such devices to monitor glucose levels in Japan as well. This, in turn, fosters the point-of-care glucose testing market growth in Japan.

Key Benefits For Stakeholders

Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.

Analyze the key strategies adopted by major market players in Japan point-of-care glucose testing market.

Assess and rank the top factors that are expected to affect the growth of Japan point-of-care glucose testing market.

Top Player positioning provides a clear understanding of the present position of market players.

Detailed analysis of the Japan point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.

Identify key investment pockets for various offerings in the market.
Product Benchmarking / Product specification and applications
Upcoming/New Entrant by Regions
New Product Development/ Product Matrix of Key Players
Patient/epidemiology data at country, region, global level
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

Lancing Devices and Strips
Blood-Glucose Meter
Type
Lifescan OneTouch Ultra and Lifescan OneTouch Verio
Accu-Chek Aviva Plus and Accuchek
Freestyle Lite and Freestyle Precission Neo
Contour Next
Others

By Application

Type-1 Diabetes
Type-2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

Key Market Players

Abbott Laboratories
Roche Diagnostics
Sysmex Corporation
Siemens Healthcare
Arkray Inc.
Otsuka Pharmaceutical Co.
FUJIFILM Holdings Corp.
ETHICON, Inc.
Novo Nordisk A/S
OLYMPUS CORPORATION

Please Note: It will take 7-10 business days to complete the report upon order confirmation. 

Table of Contents

86 Pages
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Roche Diagnostics
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Sysmex Corporation
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthcare
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Arkray Inc.
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Otsuka Pharmaceutical Co.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. FUJIFILM Holdings Corp.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. ETHICON, Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Novo Nordisk A/S
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. OLYMPUS CORPORATION
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 05. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 06. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 07. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 08. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 09. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 10. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 11. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 12. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 13. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 14. SYSMEX CORPORATION: KEY EXECUTIVES
TABLE 15. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 16. SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 17. SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 18. SYSMEX CORPORATION: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHCARE: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHCARE: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHCARE: KEY STRATERGIES
TABLE 24. ARKRAY INC.: KEY EXECUTIVES
TABLE 25. ARKRAY INC.: COMPANY SNAPSHOT
TABLE 26. ARKRAY INC.: OPERATING SEGMENTS
TABLE 27. ARKRAY INC.: PRODUCT PORTFOLIO
TABLE 28. ARKRAY INC.: KEY STRATERGIES
TABLE 29. OTSUKA PHARMACEUTICAL CO.: KEY EXECUTIVES
TABLE 30. OTSUKA PHARMACEUTICAL CO.: COMPANY SNAPSHOT
TABLE 31. OTSUKA PHARMACEUTICAL CO.: OPERATING SEGMENTS
TABLE 32. OTSUKA PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 33. OTSUKA PHARMACEUTICAL CO.: KEY STRATERGIES
TABLE 34. FUJIFILM HOLDINGS CORP.: KEY EXECUTIVES
TABLE 35. FUJIFILM HOLDINGS CORP.: COMPANY SNAPSHOT
TABLE 36. FUJIFILM HOLDINGS CORP.: OPERATING SEGMENTS
TABLE 37. FUJIFILM HOLDINGS CORP.: PRODUCT PORTFOLIO
TABLE 38. FUJIFILM HOLDINGS CORP.: KEY STRATERGIES
TABLE 39. ETHICON, INC.: KEY EXECUTIVES
TABLE 40. ETHICON, INC.: COMPANY SNAPSHOT
TABLE 41. ETHICON, INC.: OPERATING SEGMENTS
TABLE 42. ETHICON, INC.: PRODUCT PORTFOLIO
TABLE 43. ETHICON, INC.: KEY STRATERGIES
TABLE 44. NOVO NORDISK A/S: KEY EXECUTIVES
TABLE 45. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 46. NOVO NORDISK A/S: OPERATING SEGMENTS
TABLE 47. NOVO NORDISK A/S: PRODUCT PORTFOLIO
TABLE 48. NOVO NORDISK A/S: KEY STRATERGIES
TABLE 49. OLYMPUS CORPORATION: KEY EXECUTIVES
TABLE 50. OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 51. OLYMPUS CORPORATION: OPERATING SEGMENTS
TABLE 52. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
TABLE 53. OLYMPUS CORPORATION: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT LABORATORIES: NET SALES, 2020-2022* ($MILLION)
FIGURE 21. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ROCHE DIAGNOSTICS: NET SALES, 2020-2022* ($MILLION)
FIGURE 24. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. SYSMEX CORPORATION: NET SALES, 2020-2022* ($MILLION)
FIGURE 27. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. SYSMEX CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHCARE: NET SALES, 2020-2022* ($MILLION)
FIGURE 30. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHCARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. ARKRAY INC.: NET SALES, 2020-2022* ($MILLION)
FIGURE 33. ARKRAY INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. ARKRAY INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. OTSUKA PHARMACEUTICAL CO.: NET SALES, 2020-2022* ($MILLION)
FIGURE 36. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. FUJIFILM HOLDINGS CORP.: NET SALES, 2020-2022* ($MILLION)
FIGURE 39. FUJIFILM HOLDINGS CORP.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. FUJIFILM HOLDINGS CORP.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. ETHICON, INC.: NET SALES, 2020-2022* ($MILLION)
FIGURE 42. ETHICON, INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. ETHICON, INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. NOVO NORDISK A/S: NET SALES, 2020-2022* ($MILLION)
FIGURE 45. NOVO NORDISK A/S: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. NOVO NORDISK A/S: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. OLYMPUS CORPORATION: NET SALES, 2020-2022* ($MILLION)
FIGURE 48. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. OLYMPUS CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us